Hepatitis C Virus
Total core antigen assay is useful in diagnosing hepatitis C virus infection
Published in Hepatitis Weekly, January 2nd, 2006
"Hemodialysis patients are recognized as a group at high risk of infection with HCV. Therefore, such a population should be screened routinely for the presence of HCV viremia."
"Since nucleic acid techniques remain expensive and largely unavailable in many laboratories in the developing world, the present study assesses the clinical usefulness of the HCV core antigen enzyme immunoassay for the diagnosis of HCV infection in dialysis patients," wrote N. Bouzgarrou and colleagues, Laboratory of Molecular Immuno-Oncology.
"One...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-01-02)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Maturation of the hepatitis B virus core modeled structurally - Hepatitis B Virus
Tumor necrosis factor gene polymorphisms influence hepatitis B infection - Hepatitis C Virus
Hairpin ribozymes inhibit RNA replication and protein translation from HCV subgenomic replicons - Hepatitis C Virus
Hepatitis C virus found in the semen of men coinfected with HIV-1 - Cancer Therapy
Dimethyl dicarboxylate biphenyl is chemoprotective for liver epithelial cells - Chronic Hepatitis B
Post-treatment relapse factors clarified in chronic hepatitis B patients - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
